The global Coagulation Factor II Antibody market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Monoclonal Antibody Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Coagulation Factor II Antibody include MyBiosource, Inc., LifeSpan BioSciences, Inc, Assay Genie, Arigo Biolaboratories Corp., RayBiotech, Inc., Biorbyt, Creative Biolabs, GeneTex and OriGene Technologies, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Coagulation Factor II Antibody is an unconjugated antibody to Coagulation Factor II.
This report aims to provide a comprehensive presentation of the global market for Coagulation Factor II Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor II Antibody. This report contains market size and forecasts of Coagulation Factor II Antibody in global, including the following market information:
Global Coagulation Factor II Antibody Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Coagulation Factor II Antibody Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Coagulation Factor II Antibody companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Coagulation Factor II Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coagulation Factor II Antibody Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Coagulation Factor II Antibody Market Segment Percentages, by Type, 2023 (%)
Monoclonal Antibody
Polyclonal Antibody
Global Coagulation Factor II Antibody Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Coagulation Factor II Antibody Market Segment Percentages, by Application, 2023 (%)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Global Coagulation Factor II Antibody Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Coagulation Factor II Antibody Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coagulation Factor II Antibody revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Coagulation Factor II Antibody revenues share in global market, 2023 (%)
Key companies Coagulation Factor II Antibody sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Coagulation Factor II Antibody sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Assay Genie
Arigo Biolaboratories Corp.
RayBiotech, Inc.
Biorbyt
Creative Biolabs
GeneTex
OriGene Technologies, Inc.
??Abcam
Cell Signaling Technology, Inc.
Abbexa
Bio-Techne
Outline of Major Chapters:
Chapter 1: Introduces the definition of Coagulation Factor II Antibody, market overview.
Chapter 2: Global Coagulation Factor II Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Coagulation Factor II Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coagulation Factor II Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Coagulation Factor II Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Coagulation Factor II Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Coagulation Factor II Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Coagulation Factor II Antibody Overall Market Size
2.1 Global Coagulation Factor II Antibody Market Size: 2023 VS 2030
2.2 Global Coagulation Factor II Antibody Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Coagulation Factor II Antibody Sales: 2019-2030
3 Company Landscape
3.1 Top Coagulation Factor II Antibody Players in Global Market
3.2 Top Global Coagulation Factor II Antibody Companies Ranked by Revenue
3.3 Global Coagulation Factor II Antibody Revenue by Companies
3.4 Global Coagulation Factor II Antibody Sales by Companies
3.5 Global Coagulation Factor II Antibody Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Coagulation Factor II Antibody Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Coagulation Factor II Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Coagulation Factor II Antibody Players in Global Market
3.8.1 List of Global Tier 1 Coagulation Factor II Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Coagulation Factor II Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Coagulation Factor II Antibody Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibody
4.1.3 Polyclonal Antibody
4.2 By Type - Global Coagulation Factor II Antibody Revenue & Forecasts
4.2.1 By Type - Global Coagulation Factor II Antibody Revenue, 2019-2024
4.2.2 By Type - Global Coagulation Factor II Antibody Revenue, 2025-2030
4.2.3 By Type - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
4.3 By Type - Global Coagulation Factor II Antibody Sales & Forecasts
4.3.1 By Type - Global Coagulation Factor II Antibody Sales, 2019-2024
4.3.2 By Type - Global Coagulation Factor II Antibody Sales, 2025-2030
4.3.3 By Type - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
4.4 By Type - Global Coagulation Factor II Antibody Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Coagulation Factor II Antibody Market Size, 2023 & 2030
5.1.2 Flow Cytometry
5.1.3 ELISA
5.1.4 Western Blot
5.1.5 Immunoprecipitation
5.1.6 Immunofluorescence
5.1.7 Other
5.2 By Application - Global Coagulation Factor II Antibody Revenue & Forecasts
5.2.1 By Application - Global Coagulation Factor II Antibody Revenue, 2019-2024
5.2.2 By Application - Global Coagulation Factor II Antibody Revenue, 2025-2030
5.2.3 By Application - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
5.3 By Application - Global Coagulation Factor II Antibody Sales & Forecasts
5.3.1 By Application - Global Coagulation Factor II Antibody Sales, 2019-2024
5.3.2 By Application - Global Coagulation Factor II Antibody Sales, 2025-2030
5.3.3 By Application - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
5.4 By Application - Global Coagulation Factor II Antibody Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Coagulation Factor II Antibody Market Size, 2023 & 2030
6.2 By Region - Global Coagulation Factor II Antibody Revenue & Forecasts
6.2.1 By Region - Global Coagulation Factor II Antibody Revenue, 2019-2024
6.2.2 By Region - Global Coagulation Factor II Antibody Revenue, 2025-2030
6.2.3 By Region - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
6.3 By Region - Global Coagulation Factor II Antibody Sales & Forecasts
6.3.1 By Region - Global Coagulation Factor II Antibody Sales, 2019-2024
6.3.2 By Region - Global Coagulation Factor II Antibody Sales, 2025-2030
6.3.3 By Region - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Coagulation Factor II Antibody Revenue, 2019-2030
6.4.2 By Country - North America Coagulation Factor II Antibody Sales, 2019-2030
6.4.3 US Coagulation Factor II Antibody Market Size, 2019-2030
6.4.4 Canada Coagulation Factor II Antibody Market Size, 2019-2030
6.4.5 Mexico Coagulation Factor II Antibody Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Coagulation Factor II Antibody Revenue, 2019-2030
6.5.2 By Country - Europe Coagulation Factor II Antibody Sales, 2019-2030
6.5.3 Germany Coagulation Factor II Antibody Market Size, 2019-2030
6.5.4 France Coagulation Factor II Antibody Market Size, 2019-2030
6.5.5 U.K. Coagulation Factor II Antibody Market Size, 2019-2030
6.5.6 Italy Coagulation Factor II Antibody Market Size, 2019-2030
6.5.7 Russia Coagulation Factor II Antibody Market Size, 2019-2030
6.5.8 Nordic Countries Coagulation Factor II Antibody Market Size, 2019-2030
6.5.9 Benelux Coagulation Factor II Antibody Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Coagulation Factor II Antibody Revenue, 2019-2030
6.6.2 By Region - Asia Coagulation Factor II Antibody Sales, 2019-2030
6.6.3 China Coagulation Factor II Antibody Market Size, 2019-2030
6.6.4 Japan Coagulation Factor II Antibody Market Size, 2019-2030
6.6.5 South Korea Coagulation Factor II Antibody Market Size, 2019-2030
6.6.6 Southeast Asia Coagulation Factor II Antibody Market Size, 2019-2030
6.6.7 India Coagulation Factor II Antibody Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Coagulation Factor II Antibody Revenue, 2019-2030
6.7.2 By Country - South America Coagulation Factor II Antibody Sales, 2019-2030
6.7.3 Brazil Coagulation Factor II Antibody Market Size, 2019-2030
6.7.4 Argentina Coagulation Factor II Antibody Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Coagulation Factor II Antibody Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Coagulation Factor II Antibody Sales, 2019-2030
6.8.3 Turkey Coagulation Factor II Antibody Market Size, 2019-2030
6.8.4 Israel Coagulation Factor II Antibody Market Size, 2019-2030
6.8.5 Saudi Arabia Coagulation Factor II Antibody Market Size, 2019-2030
6.8.6 UAE Coagulation Factor II Antibody Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 MyBiosource, Inc.
7.1.1 MyBiosource, Inc. Company Summary
7.1.2 MyBiosource, Inc. Business Overview
7.1.3 MyBiosource, Inc. Coagulation Factor II Antibody Major Product Offerings
7.1.4 MyBiosource, Inc. Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.1.5 MyBiosource, Inc. Key News & Latest Developments
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Company Summary
7.2.2 LifeSpan BioSciences, Inc Business Overview
7.2.3 LifeSpan BioSciences, Inc Coagulation Factor II Antibody Major Product Offerings
7.2.4 LifeSpan BioSciences, Inc Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.2.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.3 Assay Genie
7.3.1 Assay Genie Company Summary
7.3.2 Assay Genie Business Overview
7.3.3 Assay Genie Coagulation Factor II Antibody Major Product Offerings
7.3.4 Assay Genie Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.3.5 Assay Genie Key News & Latest Developments
7.4 Arigo Biolaboratories Corp.
7.4.1 Arigo Biolaboratories Corp. Company Summary
7.4.2 Arigo Biolaboratories Corp. Business Overview
7.4.3 Arigo Biolaboratories Corp. Coagulation Factor II Antibody Major Product Offerings
7.4.4 Arigo Biolaboratories Corp. Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.4.5 Arigo Biolaboratories Corp. Key News & Latest Developments
7.5 RayBiotech, Inc.
7.5.1 RayBiotech, Inc. Company Summary
7.5.2 RayBiotech, Inc. Business Overview
7.5.3 RayBiotech, Inc. Coagulation Factor II Antibody Major Product Offerings
7.5.4 RayBiotech, Inc. Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.5.5 RayBiotech, Inc. Key News & Latest Developments
7.6 Biorbyt
7.6.1 Biorbyt Company Summary
7.6.2 Biorbyt Business Overview
7.6.3 Biorbyt Coagulation Factor II Antibody Major Product Offerings
7.6.4 Biorbyt Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.6.5 Biorbyt Key News & Latest Developments
7.7 Creative Biolabs
7.7.1 Creative Biolabs Company Summary
7.7.2 Creative Biolabs Business Overview
7.7.3 Creative Biolabs Coagulation Factor II Antibody Major Product Offerings
7.7.4 Creative Biolabs Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.7.5 Creative Biolabs Key News & Latest Developments
7.8 GeneTex
7.8.1 GeneTex Company Summary
7.8.2 GeneTex Business Overview
7.8.3 GeneTex Coagulation Factor II Antibody Major Product Offerings
7.8.4 GeneTex Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.8.5 GeneTex Key News & Latest Developments
7.9 OriGene Technologies, Inc.
7.9.1 OriGene Technologies, Inc. Company Summary
7.9.2 OriGene Technologies, Inc. Business Overview
7.9.3 OriGene Technologies, Inc. Coagulation Factor II Antibody Major Product Offerings
7.9.4 OriGene Technologies, Inc. Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.9.5 OriGene Technologies, Inc. Key News & Latest Developments
7.10 ??Abcam
7.10.1 ??Abcam Company Summary
7.10.2 ??Abcam Business Overview
7.10.3 ??Abcam Coagulation Factor II Antibody Major Product Offerings
7.10.4 ??Abcam Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.10.5 ??Abcam Key News & Latest Developments
7.11 Cell Signaling Technology, Inc.
7.11.1 Cell Signaling Technology, Inc. Company Summary
7.11.2 Cell Signaling Technology, Inc. Coagulation Factor II Antibody Business Overview
7.11.3 Cell Signaling Technology, Inc. Coagulation Factor II Antibody Major Product Offerings
7.11.4 Cell Signaling Technology, Inc. Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.11.5 Cell Signaling Technology, Inc. Key News & Latest Developments
7.12 Abbexa
7.12.1 Abbexa Company Summary
7.12.2 Abbexa Coagulation Factor II Antibody Business Overview
7.12.3 Abbexa Coagulation Factor II Antibody Major Product Offerings
7.12.4 Abbexa Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.12.5 Abbexa Key News & Latest Developments
7.13 Bio-Techne
7.13.1 Bio-Techne Company Summary
7.13.2 Bio-Techne Coagulation Factor II Antibody Business Overview
7.13.3 Bio-Techne Coagulation Factor II Antibody Major Product Offerings
7.13.4 Bio-Techne Coagulation Factor II Antibody Sales and Revenue in Global (2019-2024)
7.13.5 Bio-Techne Key News & Latest Developments
8 Global Coagulation Factor II Antibody Production Capacity, Analysis
8.1 Global Coagulation Factor II Antibody Production Capacity, 2019-2030
8.2 Coagulation Factor II Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Coagulation Factor II Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Coagulation Factor II Antibody Supply Chain Analysis
10.1 Coagulation Factor II Antibody Industry Value Chain
10.2 Coagulation Factor II Antibody Upstream Market
10.3 Coagulation Factor II Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Coagulation Factor II Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Coagulation Factor II Antibody in Global Market
Table 2. Top Coagulation Factor II Antibody Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Coagulation Factor II Antibody Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Coagulation Factor II Antibody Revenue Share by Companies, 2019-2024
Table 5. Global Coagulation Factor II Antibody Sales by Companies, (K Units), 2019-2024
Table 6. Global Coagulation Factor II Antibody Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Coagulation Factor II Antibody Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Coagulation Factor II Antibody Product Type
Table 9. List of Global Tier 1 Coagulation Factor II Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Coagulation Factor II Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Coagulation Factor II Antibody Sales (K Units), 2019-2024
Table 15. By Type - Global Coagulation Factor II Antibody Sales (K Units), 2025-2030
Table 16. By Application ? Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Coagulation Factor II Antibody Sales (K Units), 2019-2024
Table 20. By Application - Global Coagulation Factor II Antibody Sales (K Units), 2025-2030
Table 21. By Region ? Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Coagulation Factor II Antibody Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Coagulation Factor II Antibody Sales (K Units), 2019-2024
Table 25. By Region - Global Coagulation Factor II Antibody Sales (K Units), 2025-2030
Table 26. By Country - North America Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Coagulation Factor II Antibody Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Coagulation Factor II Antibody Sales, (K Units), 2019-2024
Table 29. By Country - North America Coagulation Factor II Antibody Sales, (K Units), 2025-2030
Table 30. By Country - Europe Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Coagulation Factor II Antibody Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Coagulation Factor II Antibody Sales, (K Units), 2019-2024
Table 33. By Country - Europe Coagulation Factor II Antibody Sales, (K Units), 2025-2030
Table 34. By Region - Asia Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Coagulation Factor II Antibody Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Coagulation Factor II Antibody Sales, (K Units), 2019-2024
Table 37. By Region - Asia Coagulation Factor II Antibody Sales, (K Units), 2025-2030
Table 38. By Country - South America Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Coagulation Factor II Antibody Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Coagulation Factor II Antibody Sales, (K Units), 2019-2024
Table 41. By Country - South America Coagulation Factor II Antibody Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Coagulation Factor II Antibody Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Coagulation Factor II Antibody Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Coagulation Factor II Antibody Sales, (K Units), 2025-2030
Table 46. MyBiosource, Inc. Company Summary
Table 47. MyBiosource, Inc. Coagulation Factor II Antibody Product Offerings
Table 48. MyBiosource, Inc. Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. MyBiosource, Inc. Key News & Latest Developments
Table 50. LifeSpan BioSciences, Inc Company Summary
Table 51. LifeSpan BioSciences, Inc Coagulation Factor II Antibody Product Offerings
Table 52. LifeSpan BioSciences, Inc Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. LifeSpan BioSciences, Inc Key News & Latest Developments
Table 54. Assay Genie Company Summary
Table 55. Assay Genie Coagulation Factor II Antibody Product Offerings
Table 56. Assay Genie Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Assay Genie Key News & Latest Developments
Table 58. Arigo Biolaboratories Corp. Company Summary
Table 59. Arigo Biolaboratories Corp. Coagulation Factor II Antibody Product Offerings
Table 60. Arigo Biolaboratories Corp. Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Arigo Biolaboratories Corp. Key News & Latest Developments
Table 62. RayBiotech, Inc. Company Summary
Table 63. RayBiotech, Inc. Coagulation Factor II Antibody Product Offerings
Table 64. RayBiotech, Inc. Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. RayBiotech, Inc. Key News & Latest Developments
Table 66. Biorbyt Company Summary
Table 67. Biorbyt Coagulation Factor II Antibody Product Offerings
Table 68. Biorbyt Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Biorbyt Key News & Latest Developments
Table 70. Creative Biolabs Company Summary
Table 71. Creative Biolabs Coagulation Factor II Antibody Product Offerings
Table 72. Creative Biolabs Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Creative Biolabs Key News & Latest Developments
Table 74. GeneTex Company Summary
Table 75. GeneTex Coagulation Factor II Antibody Product Offerings
Table 76. GeneTex Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. GeneTex Key News & Latest Developments
Table 78. OriGene Technologies, Inc. Company Summary
Table 79. OriGene Technologies, Inc. Coagulation Factor II Antibody Product Offerings
Table 80. OriGene Technologies, Inc. Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. OriGene Technologies, Inc. Key News & Latest Developments
Table 82. ??Abcam Company Summary
Table 83. ??Abcam Coagulation Factor II Antibody Product Offerings
Table 84. ??Abcam Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. ??Abcam Key News & Latest Developments
Table 86. Cell Signaling Technology, Inc. Company Summary
Table 87. Cell Signaling Technology, Inc. Coagulation Factor II Antibody Product Offerings
Table 88. Cell Signaling Technology, Inc. Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Cell Signaling Technology, Inc. Key News & Latest Developments
Table 90. Abbexa Company Summary
Table 91. Abbexa Coagulation Factor II Antibody Product Offerings
Table 92. Abbexa Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Abbexa Key News & Latest Developments
Table 94. Bio-Techne Company Summary
Table 95. Bio-Techne Coagulation Factor II Antibody Product Offerings
Table 96. Bio-Techne Coagulation Factor II Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Bio-Techne Key News & Latest Developments
Table 98. Coagulation Factor II Antibody Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Coagulation Factor II Antibody Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Coagulation Factor II Antibody Production by Region, 2019-2024 (K Units)
Table 101. Global Coagulation Factor II Antibody Production by Region, 2025-2030 (K Units)
Table 102. Coagulation Factor II Antibody Market Opportunities & Trends in Global Market
Table 103. Coagulation Factor II Antibody Market Drivers in Global Market
Table 104. Coagulation Factor II Antibody Market Restraints in Global Market
Table 105. Coagulation Factor II Antibody Raw Materials
Table 106. Coagulation Factor II Antibody Raw Materials Suppliers in Global Market
Table 107. Typical Coagulation Factor II Antibody Downstream
Table 108. Coagulation Factor II Antibody Downstream Clients in Global Market
Table 109. Coagulation Factor II Antibody Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Coagulation Factor II Antibody Segment by Type in 2023
Figure 2. Coagulation Factor II Antibody Segment by Application in 2023
Figure 3. Global Coagulation Factor II Antibody Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Coagulation Factor II Antibody Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Coagulation Factor II Antibody Revenue, 2019-2030 (US$, Mn)
Figure 7. Coagulation Factor II Antibody Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Coagulation Factor II Antibody Revenue in 2023
Figure 9. By Type - Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 11. By Type - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 12. By Type - Global Coagulation Factor II Antibody Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 15. By Application - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 16. By Application - Global Coagulation Factor II Antibody Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Coagulation Factor II Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Coagulation Factor II Antibody Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 20. By Region - Global Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 21. By Country - North America Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 22. By Country - North America Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 23. US Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 28. Germany Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 29. France Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 37. China Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 41. India Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 43. By Country - South America Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 44. Brazil Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Coagulation Factor II Antibody Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Coagulation Factor II Antibody Sales Market Share, 2019-2030
Figure 48. Turkey Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Coagulation Factor II Antibody Revenue, (US$, Mn), 2019-2030
Figure 52. Global Coagulation Factor II Antibody Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Coagulation Factor II Antibody by Region, 2023 VS 2030
Figure 54. Coagulation Factor II Antibody Industry Value Chain
Figure 55. Marketing Channels
